This inventor holds 1 USPTO granted patent. Top assignee: Enterobiome Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Yoonmi Lee - Innovator in Pharmaceutical Composition
Introduction
Yoonmi Lee is a notable inventor based in Goyang-si, Gyeonggi-do, South Korea. She has made significant contributions to the field of pharmaceuticals, particularly in the area of atopic diseases. Her innovative work has led to the development of a unique pharmaceutical composition that showcases her expertise and dedication to improving health outcomes.
Latest Patents
Yoonmi Lee holds a patent for a "Pharmaceutical Composition for Preventing or Treating Atopic Disease Containing Faecalibacterium Prausnitzii Strain." This patent highlights her focus on utilizing beneficial bacteria to address atopic conditions, which can greatly enhance treatment options for patients suffering from these diseases. She has 1 patent to her name, reflecting her commitment to advancing medical science.
Career Highlights
Yoonmi Lee is currently employed at Enterobiome Inc., a company dedicated to innovative solutions in the field of microbiome research and its applications in health. Her role at Enterobiome Inc. allows her to collaborate with other experts in the field and contribute to groundbreaking research that has the potential to transform patient care.
Collaborations
One of her notable coworkers is Joo-Hyun Shin, who brings her own expertise to the team. Together, they work on projects that aim to enhance the understanding and treatment of various diseases through innovative approaches.
Conclusion
Yoonmi Lee's contributions to pharmaceutical innovation, particularly in the treatment of atopic diseases, underscore her role as a leading inventor in her field. Her work at Enterobiome Inc. and her patent on beneficial bacterial compositions highlight her commitment to advancing healthcare solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile